Reed L. Benson - 19 May 2021 Form 4 Insider Report for Co-Diagnostics, Inc. (CODX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
21 May 2021, 12:43:07 UTC
Next SEC filing
26 May 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Reed L. Benson

Key filing fact

Reed L. Benson filed Form 4 for Co-Diagnostics, Inc. (CODX) on 21 May 2021.

Key facts

  • This page summarizes Reed L. Benson's Form 4 filing for Co-Diagnostics, Inc. (CODX).
  • 9 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 21 May 2021, 12:43.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: -$638,711.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CODX transaction

Common Stock

Options Exercise

Transaction value
$1.1
Shares
+1
Change %
Price
$1.10
Shares after
1
Date
19 May 2021
Ownership
Direct
CODX transaction

Common Stock

Options Exercise

Transaction value
$28,720
Shares
+10,920
Change %
+1092000%
Price
$2.63
Shares after
10,921
Date
19 May 2021
Ownership
Direct
CODX transaction

Common Stock

Options Exercise

Transaction value
$256,196
Shares
+97,413
Change %
+892%
Price
$2.63
Shares after
108,334
Date
19 May 2021
Ownership
Direct
CODX transaction

Common Stock

Sale

Transaction value
$93,232
Shares
-10,920
Change %
-10%
Price
$8.54*
Shares after
97,414
Date
19 May 2021
Ownership
Direct
Footnotes
F1
CODX transaction

Common Stock

Sale

Transaction value
$830,387
Shares
-97,413
Change %
-100%
Price
$8.52*
Shares after
1
Date
19 May 2021
Ownership
Direct
Footnotes
F2
CODX transaction

Common Stock

Sale

Transaction value
$8.53
Shares
-1
Change %
-100%
Price
$8.53*
Shares after
0
Date
19 May 2021
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CODX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-97,413
Change %
-100%
Price
$0.000000*
Shares after
0
Date
19 May 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
97,413
Exercise price
$2.63
Footnotes
F3
CODX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-10,920
Change %
-100%
Price
$0.000000*
Shares after
0
Date
19 May 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,920
Exercise price
$2.63
Footnotes
F3
CODX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-1
Change %
-0.01%
Price
$0.000000
Shares after
13,891
Date
19 May 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1
Exercise price
$1.10
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

This transaction was executed in multiple trades at prices ranging from $8.52 USD to $8.55 USD; the price reported above reflects the weighted average sale price.

Footnote F2

This transaction was executed in multiple trades at prices ranging from $8.47 USD to $8.64 USD; the price reported above reflects the weighted average sale price.

Footnote F3

1/3 on day of grant; 1/3 after year 1, 1/3 after year 2 beginning on 21-Sep-2018

Footnote F4

1/3 on day of grant; 1/3 after year 1, 1/3 after year 2 beginning on 03-Sep-2019

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .